EUCTR2005-003009-10-GB进行中（未招募）1 期
A randomized, open label pilot study to investigate the effect of chronic administration of buprenorphine prior to arthroplasty on the opioid requirements of patients intraoperatively and postoperatively. - Date: Final 26 April 2004
Barts and The London NHS Trust0 个研究点目标入组 75 人开始时间: 2005年6月30日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. Subjects who have completed the first two weeks of PRG-BUP-03/01 and require at least one Transtec® patch to achieve pain relief.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Subjects who have previously failed on Transtec® therapy.
- •2. Subjects who have received treatment with a potent opioid in the four weeks preceding study entry.
- •3. Subjects who are breastfeeding.
- •4. Contraindications to Transtec® or Temgesic® as listed in their respective Summary of Product Characteristics.
- •5. Subjects with documented or suspected alcohol or drug abuse, or who are suspected of having an addictive personality.
- •6. Subjects to whom any of the following applies
- •Major trauma to the target joints in the six months preceding study entry
- •Infection in the target joints in the six months preceding study entry;
- •Apparent avascular necrosis in the target joints in the six months preceding study entry;
- •Intra-articular injections of corticosteroids in the target joints in the two months preceding study entry, or hyaluronan injections in the target joints in the six months preceding study entry.
- •Subjects who have started any form of physiotherapy, massage or physical therapy, transcutaneous electrical nerve stimulation (TENS) in the three weeks preceding the study. Such therapies can continue if they were started more than three weeks before the start of the study and if they continue at the same frequency of administration throughout the study.
- •7. Subjects for whom a treatment is planned within the study period that could alter the degree or nature of pain.
- •8. Subjects known to have a condition that in the investigator’s judgement precludes participation in the study.
- •9. Subjects with a significant psychiatric disorder (including depression) or subjects receiving anti-psychotic medication.
- •10. Subjects who have received an investigational drug or have used an investigational device in the 30 days preceding to study entry except those used in PRG-BUP-03/01.
- •11. Subjects unable to comply with the study assessments and to complete the questionnaires
研究者
相似试验
进行中（未招募）
不适用
An open label, randomized pilot study to evaluate diagnostic treatment interruption in HIV-positive children under a stable antiretroviral therapy in order to save medication and reduce possible side effects.B24Unspecified human immunodeficiency virus [HIV] diseaseDRKS00000473J.W. Goethe UniversitätZentrum für Kinder- und Jugendmedizin1
招募中
2 期
Study to evaluate the efficacy of Sucralfate as a healing agent in bed sores.CTRI/2016/03/006745Internal FLUID Grant Christian Medical College Vellore30
进行中（未招募）
1 期
An open label, randomized pilot study evaluating the early conversion from calcineurin inhibitors to Rapamune in patients with impaired renal function following kidney transplantation - Sirolimus Switch StudyEUCTR2004-004884-31-GBewcastle upon Tyne Hospitals NHS Trust60
招募中
3 期
A Prospective, Open-label Pilot Study to Evaluate Effector mechanisms of Hyperbaric Oxygen Therapy in Patients with Moderate-to-Severe Ulcerative Colitis: The PARADOX study10017969ulcerative colitisIBDNL-OMON52110Academisch Medisch Centrum24
已完成
不适用
An open label, cross over pilot study to evaluate the effect of a single dose of TW001 on the oxidative stress and pharmacokinetics with and without food in patients with amyotrophic lateral sclerosisNL-OMON42324Treeway B.V.8